XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash flows from (used in) operating activities          
Net loss $ (1,927) $ 627 $ (6,084) $ (3,225)  
Adjustments to reconcile net loss to net cash from (used in) operating activities:          
Stock-based compensation     4,388 2,383  
Depreciation and amortization     3,027 791  
Inventory step-up     3,673 0  
Non-cash lease expense     35 53  
Debt discount amortization and non-cash interest expenses 189 29 521 70  
Changes in operating assets and liabilities:          
Accounts receivable     (7,721) (2,179)  
Inventories     (5,295) (1,027)  
Prepaid expenses and other assets     550 171  
Accounts payable     10,092 836  
Accrued Medicaid rebates     11,165 4,420  
Accrued liabilities     585 (559)  
Other non-current assets and liabilities     7,139 0  
Net cash from (used in) operating activities     22,075 1,734  
Cash flows from (used in) investing activities          
Purchases of product license rights     0 (1,868)  
Purchases of property and equipment     (284) (14)  
Net cash from (used in) investing activities     (284) (1,882)  
Cash flows from (used in) financing activities          
Repayment of long-term debt     0 (1,155)  
Proceeds from employee stock purchase plan and stock option exercises     394 176  
Net cash from (used in) financing activities     394 (979)  
Change in cash and cash equivalents     22,185 (1,127)  
Cash and cash equivalents at beginning of period     14,936 21,388 $ 21,388
Cash and cash equivalents at end of period $ 37,121 $ 20,261 37,121 20,261 $ 14,936
Supplemental disclosures of cash flow information          
Cash paid for interest     2,395 525  
Cash paid for income taxes     $ 117 $ 181